Close Menu

NEW YORK (GenomeWeb) – BG Medicine said in its most recent 10K filing that laboratory firm True Health Diagnostics (THD) has declined to assume a supply agreement for BG's galectin-3 tests.

The agreement was originally established between BG and Health Diagnostics Laboratory (HDL), which filed for bankruptcy in June 2015. THD last year acquired the assets of HDL, which was formerly BG's largest customer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.

Apr
30
Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.